SB-431542 and Gleevec Inhibit Transforming Growth Factor-β-Induced Proliferation of Human Osteosarcoma Cells

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7791-7798

  Matsuyama, Shigeo ^a,b,c   Iwadate, Manabu ^b   Kondo, Miki ^a,b   Saitoh, Masao ^a   Hanyu, Aki ^b   Shimizu, Kiyoshi ^d   Aburatani, Hiroyuki ^e   Mishima, Hiromu K ^c   Imamura, Takeshi ^b   Miyazono, Kohei ^a,b   Miyazawa, Keiji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^d KIRIN BREWERY CO LTD   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; IMATINIB; PHOSPHOTRANSFERASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; HUMAN; HUMAN CELL; ONCOGENE C MYC; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TARGET CELL;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ANIMALS; ANTINEOPLASTIC AGENTS; BENZAMIDES; BONE NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DIOXOLES; DRUG INTERACTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-MYC; PYRIMIDINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 10744225133     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Miyazono, K., Kusanagi, K., and Inoue, H. Divergence and convergence of TGF-β/BMP signaling. J. Cell. Physiol., 187: 265-276, 2001.
2. Massagué, J., Blain, S. W., and Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell, 103: 295-309, 2000.
3. ten Dijke, P., Goumans, M-J., Itoh, F., and Itoh, S. Regulation of cell proliferation by Smad proteins. J, Cell. Physiol., 191: 1-16, 2002.
4. Moses, H. L., Yang, E. Y., and Pietenpol, J. A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63: 245-247, 1990.
5. Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe. P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., and Li, E. Activin receptor like kinase-1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA, 97: 2626-2631, 2000.
6. Miyazono, K., ten Dijke, P., and Heldin, C-H. TGF-β signaling by Smad proteins. Adv. Immunol., 75: 115-157. 2000.
7. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., and, Kato, M. c-myc is a downstream target of the Smad pathway. J. Biol. Chem., 277: 854-861, 2002.
8. Chen, C-R., Kang, Y., Siegel, P. M., and Massagué, J. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell, 110: 19-32, 2002.
9. Ink4B. Mol. Cell, 9: 135-143, 2002.
10. WAF1/CIP1 regulation by transforming growth factor-β. J. Biol. Chem., 275: 29224-29256, 2000.
11. Leof, E. B., Proper, J. A., Goustin, A. S., Shipley, G. D., DiCorleto, P. E., and Moses, H. L. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA, 83: 2453-2457, 1986.
12. Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., and Ross, R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell, 63: 515-524, 1990.
13. Win, K. M., Charlotte, F., Mallat, A., Cherqui, D., Martin, N., Mavier, P., Preaux, A. M., Dhumeaux, D., and Rosenbaum, J. Mitogenic effect of transforming growth factor-β1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology, 18: 137-145, 1993.
14. Seifert, R. A., Coats, S. A., Raines, E. W., Ross, R., and Bowen-Pope, D. F. Platelet-derived growth factor (PDGF) receptor a-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-β can be mitogenic through PDGF A-chain-dependent and -independent pathways. J. Biol. Chem., 269: 13951-13955, 1994.
15. Sintich, S. M., Lamm, M. L. G., Sensibar, J. A., and Lee, C. Transforming growth factor-β1-induced proliferation of the prostate cancer cell line. TSU-Pr1: the role of platelet-derived growth factor. Endocrinology, 140: 3411-3415, 1999.
16. Kay, E. P., Lee, H. K., Park, K. S., and Lee, S. C. Indirect mitogenic effect of transforming growth factor-β on cell proliferation of subconjunctival fibroblasts. Invest. Ophthalmol. Vis. Sci., 39: 181-486, 1998.
17. Kay, E. P., Lee, M. S., Seong, G. J., and Lee, Y. G. TGF-βs stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts. Curr. Eye Res., 17: 286-293, 1998.
18. Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., van Kooten, C., and Müller, G. A. TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int., 59: 579-592, 2001.
19. Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1. J. Biol. Chem., 274: 12197-12200, 1999.
20. Kip2 proteolysis in osteoblastic cells. J. Biol. Chem., 276: 10700-10705, 2001.
21. Yan, Z., Kim, G-Y., Deng, X., and Friedman, E. Transforming growth factor β1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. J. Biol. Chem., 277: 9870-9879, 2002.
22. Goumans, M-J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., and ten Dijke, P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J., 21: 1743-1753, 2002.
23. Ragland, B. D., Bell, W. C., Lopez, R. R., and Siegal, G. P. Cytogenetics and molecular biology of osteosarcoma. Lab. Invest., 82: 365-373, 2002.
24. Seyedin, S. M., Thompson, A. Y., Bentz, H., Rosen, D. M., McPherson, J. M., Conti, A., Siegel, N. R., Galluppi, G. R., and Piez, K. A. Cartilage-inducing factor-A: apparent identity to transforming growth factor-β. J. Biol. Chem., 261: 5693-5695, 1986.
25. Pfeilschifter, J., D'Souza, S. M., and Mundy, G. R. Effects of transforming growth factor-β on osteoblastic osteosarcoma cells. Endocrinology, 121: 212-218, 1987.
26. Kloen, P., Jennings, C. L., Gebhardt, M. C., Springfield, D. S., and Mankin, H. J. Expression of transforming growth factor-β (TGF-β) receptors, TGF-β1 and TGF-β2 production and autocrine growth control in osteosarcoma cells. Int. J. Cancer, 58: 440-445, 1994.
27. 3H]thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor β. J. Bone Miner. Res., 8: 19-25, 1993.
28. Franchi, A., Arganini, L., Baroni, G., Calzolari, A., Capanna, R., Campanacci, D., Caldora, P., Masi, L., Brandi, M. L., and Zampi, G. Expression of transforming growth factor β isoforms in osteosarcoma variants: association of TGF β1 with high-grade osteosarcomas. J. Pathol., 185: 284-289, 1998.
29. Kloen, P., Gebhardt, M. C., Perez-Atayde, A., Rosenberg, A. E., Springfield, D. S., Gold, L. I., and Mankin, H. J. Expression of transforming growth factor-β (TGF-β) isoforms in osteosarcomas: TGF-β3 is related to disease progression. Cancer (Phila.), 80: 2230-2239, 1997.
30. Callahan, J. F., Burgess, J. L., Fornbald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., Olson, B. A., Weinstock, J., and Laping, N. J. Identification of novel inhibitors of the transforming growth factor-β1 (TGF-β1) type 1 receptor (ALK5). J. Med. Chem., 45: 999-1001, 2002.
31. ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., and Heldin, C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science (Wash. DC), 264: 101-104, 1994.
32. Fujii, M., Takeda, K., Imamura, T., Aoki, H., Sampath. T. K., Enomoto, S., Kawabata, M., Kato, M., Ichijo, H., and Miyazono, K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell, 10: 3801-3813, 1999.
33. Ota, T., Fujii, M., Sugizaki, T., Ishii, M., Miyazawa, K., Aburatani, H., and Miyazono, K. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-β in human umbilical vein endothelial cells. J. Cell. Physiol., 193: 299-318, 2002.
34. Ebisawa. T., Tada, K., Kitajima, I., Tojo, K., Sampath, T. K., Kawabata, M., Miyazono, K., and Imamura, T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci., 112: 3519-3527, 1999.
35. Nishihara, A., Watabe, T., Imamura, T., and Miyazono. K. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol. Biol. Cell, 13: 3055-3063, 2002.
36. Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith. A. D., Laping, N. J., and Hill, C. S. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol., 63: 65-74, 2002.
37. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B. J., and Lydon, N. B. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res., 56: 100-104. 1996.
38. Kovalenko, M., Gazit, A., Böhmer. A., Rorsman, C., Rönnstrand, L., Heldin, C-H., Waltenberger, J., Böhmer, F. D., and Levitzki, A. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res., 54: 6106-6114, 1994.
39. Subramaniam, M., Oursler, M. J., Rasmussen, K., Riggs, B. L., and Spelsberg, T. C. TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells. J. Cell. Biochem., 57: 52-61, 1995.
40. Saito, T., Kinoshita, A., Yoshiura, K., Makita, Y., Wakui, K., Honke, K., Niikawa, N., and Taniguchi, N. Domain-specific mutations of a transforming growth factor (TGF)-β1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-β1. J. Biol. Chem., 276: 11469-11472, 2001.
41. Tokuyama, H., and Tokuyama, Y. Bovine colostric transforming growth factor-β-like peptide that induces growth inhibition and changes in morphology of human osteogenic sarcoma cells (MG-63). Cell Biol. Int. Rep., 13: 251-258, 1989.
42. Pirskanen, A., Jaaskelainen, T., and Maenpaa, P. H. Effects of transforming growth factor β1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells. J. Bone Miner. Res., 9: 1635-1642, 1994.
43. Yokota, Y., and Mori, S. Role of Id family proteins in growth control. J. Cell. Physiol., 190: 21-28, 2002.
44. Miyazaki, M., Ohashi, R., Tsuji, T., Mihara, K., Gohda, E., and Namba, M. Transforming growth factor-β1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1. Biochem. Biophys. Res. Commun., 246: 873-880, 1998.
45. Moustakas, A., and Kardassis, D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA, 95: 6733-6738, 1998.
46. Piek, E., and Roberts, A. B. Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv. Cancer Res., 83: 1-54, 2001.
47. Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C-H., and Östman, A. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res., 62: 5476-5484, 2002.